Brief: Pharvaris Says Deucrictibant Data Highlighted In Multiple Presentations At C1-Inhibitor Deficiency And Angioedema Workshop
06/05/2023 18:02
May 6 (Reuters) - Pharvaris NV PHVS.O :
* DEUCRICTIBANT DATA HIGHLIGHTED IN MULTIPLE PRESENTATIONS
AT
C1-INHIBITOR DEFICIENCY AND ANGIOEDEMA WORKSHOP
Source text for Eikon: ID:nGNX2sbWmz
Further company coverage: PHVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharvaris
See all newsU.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
U.S. STOCKS ON THE MOVE-Qualcomm, Eaton, Howmet Aerospace
Pharvaris' genetic disorder drug meets main goal in late-stage trial (updated)
U.S. STOCKS ON THE MOVE-Sigma Lithium, Shake Shack, Novartis
Pharvaris gains after genetic disorder drug meets late-stage trial goal